Pharmacogenetics goes genomic

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nature reviews genetics

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrg1229PMID 14631354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

  2003cited by this paper
• Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

  2003cited by this paper
• Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.

  2003cited by this paper
• Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure.

  2003cited by this paper
• Drug development for asthma.

  2003cited by this paper
• Pharmacogenetics.

  2003cited by this paper
• Pharmacogenetics [7] (multiple letters)

  2003cited by this paper
• Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare

  2003cited by this paper
• New estimates of drug development costs.

  2003cited by this paper
• Genome scans and candidate gene approaches in the study of common diseases and variable drug responses.

  2003cited by this paper
• Natural variation in human membrane transporter genes reveals evolutionary and functional constraints

  2003cited by this paper
• Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

  2003cited by this paper
• Prospects and Limits of Pharmacogenetics

  2003cited by this paper
• Pharmacogenetics.

  2003cited by this paper
• Mechanisms of antiepileptic drug resistance

  2003cited by this paper
• The price of innovation: new estimates of drug development costs.

  2003cited by this paper
• Pharmacogenetics in the laboratory and the clinic.

  2003cited by this paper
• Neuregulin 1 and susceptibility to schizophrenia.

  2002cited by this paper
• The significance of QT interval in drug development.

  2002cited by this paper
• A comprehensive review of genetic association studies

  2002cited by this paper
• Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro.

  2002cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal.

  2002cited by this paper
• Genome-based pharmacogenetics and the pharmaceutical industry

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Pharmacogenetics of asthma.

  2002cited by this paper
• Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.

  2002cited by this paper
• Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

  2002cited by this paper
• The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.

  2002cited by this paper
• Molecular basis of ethnic differences in drug disposition and response.

  2001cited by this paper
• Dissecting Human Disease in the Postgenomic Era

  2001cited by this paper
• High-resolution haplotype structure in the human genome

  2001cited by this paper
• Haplotype tagging for the identification of common disease genes

  2001cited by this paper
• Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review.

  2001cited by this paper
• Genomics and medicine. Dissecting human disease in the postgenomic era.

  2001cited by this paper
• The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.

  2001cited by this paper
• Detecting association in a case‐control study while correcting for population stratification

  2001cited by this paper
• Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data.

  2000cited by this paper
• Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

  2000cited by this paper
• Pharmacogenomics: The promise of personalized medicine

  2000cited by this paper
• The Evolution of Drug Metabolism

  2000cited by this paper
• Pharmacogenetics and future drug development and delivery.

  2000cited by this paper
• beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.

  1999cited by this paper
• Felbamate

  1999cited by this paper
• Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain.

  1999cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• Use of unlinked genetic markers to detect population stratification in association studies.

  1999cited by this paper
• Forced Normalization: Clinical and Therapeutic Relevance

  1999cited by this paper
• Polymorphisms of the β2-Adrenergic Receptor and Asthma

  1997cited by this paper
• Design concepts in nutritional epidemiology

  1997cited by this paper
• Polymorphisms of the beta2-adrenergic receptor and asthma.

  1997cited by this paper
• Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.

  1995cited by this paper
• The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism.

  1993cited by this paper
• Felbamate

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Design Concepts in Nutritional Epidemiology

  1992cited by this paper
• Cost of innovation in the pharmaceutical industry.

  1991cited by this paper
• Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non‐familial hypercholesterolaemia

  1991cited by this paper
• Polymorphic hydroxylation of Debrisoquine in man.

  1977cited by this paper
• Letter: Neutrophil function and myeloperoxidase activity in inflammatory bowel disease.

  1976cited by this paper
• Pharmacogenetics

  1968cited by this paper
• Drug reactions enzymes, and biochemical genetics.

  1957cited by this paper

• Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates

  2025cites this paper
• The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches

  2024cites this paper
• Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test

  2024cites this paper
• PAnno: A pharmacogenomics annotation tool for clinical genomic testing

  2023cites this paper
• Race and Ethnicity in Lewy Body Dementia: A Narrative Review

  2023cites this paper
• Individualização do tratamento com topiramato em pacientes infantis com epilepsia focal

  2023cites this paper
• Drug genetic associations with COVID-19 manifestations: a data mining and network biology approach

  2022cites this paper
• Green tea polyphenols in cardiometabolic health: A critical appraisal on Phytogenomics towards personalized green tea

  2022cites this paper
• Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria

  2021cites this paper
• A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review

  2021cites this paper
• The need to shift pharmacogenetic research from candidate gene to genome-wide association studies.

  2021cites this paper
• Discovery of disease treatment mechanisms through the multiscale interactome

  2020cites this paper
• Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms

  2020cites this paper
• Additive Manufacturing in Drug Delivery Applications: A Review.

  2020cites this paper
• Identification of disease treatment mechanisms through the multiscale interactome

  2020cites this paper
• Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities.

  2019cites this paper
• The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort study.

  2019cites this paper
• Genetic Linkage and Linkage Disequilibrium Analysis

  2018cites this paper
• Veterinary Considerations for the Theoretical Resurrection of Extinct Species

  2018cites this paper
• Advancing our understanding of the ciliopathy, Bardet-Biedl Syndrome : an omics approach

  2018cites this paper
• Molecular Biology Applications in Oral and Maxillofacial Surgery

  2018cites this paper
• DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol.

  2018cites this paper
• Type 2 Diabetes Treatment and Drug Development Study

  2018cites this paper
• Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.

  2017cites this paper
• Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines

  2017cites this paper
• 甲基化在肺癌研究领域的相关进展

  2017cites this paper
• Ayurgenomics for stratified medicine: TRISUTRA consortium initiative across ethnically and geographically diverse Indian populations.

  2017cites this paper
• Association between SSR markers and fibre traits in sea island cotton (Gossypium barbadense) germplasm resources

  2017cites this paper
• Screening for CYP2C19 Gene variants in a healthy Jordanian population

  2017cites this paper
• Genomic regions conferring resistance to multiple fungal pathogens in synthetic hexaploid wheat

  2016cites this paper
• Personalized Medicine: The Path to New Medicine

  2016cites this paper
• A comparison of two methods of template amplification for next generation sequencing: Implications of polyclonal formation on DNA sequence for several cancer tissues

  2016influential citation
• Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery

  2016cites this paper
• Pharmacogenetic Studies of Suicide: Potential Relevance of Main Polymorphic CYPs and ABCB1

  2016cites this paper
• Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer’s disease clinical trials

  2015cites this paper
• Industry-sponsored clinical research outside high-income countries: an empirical analysis of registered clinical trials from 2006 to 2013

  2015cites this paper
• DEVELOPMENT OF PHARMACEUTICAL INK FORMULATIONS WITH SILICA NANOPARTICLES FOR INKJET PRINTING

  2015cites this paper
• The complex case for another hard look : transnational pharmaceutical regulation and the pedagogical role of courts

  2015cites this paper
• Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators.

  2015cites this paper
• A penalized likelihood approach for investigating gene–drug interactions in pharmacogenetic studies

  2015cites this paper
• Resveratrol Inhibitory Effects against a Malignant Tumor

  2014cites this paper
• Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.

  2014cites this paper
• GENE-LEVEL PHARMACOGENETIC ANALYSIS ON SURVIVAL OUTCOMES USING GENE-TRAIT SIMILARITY REGRESSION.

  2014cites this paper
• Genetic improvement of Gossypium arboreum L. using molecular markers: Status and development needs

  2014cites this paper
• Treatment of Epilepsy: Background and Future Directions

  2014cites this paper
• Pharmacogenetics of Drug Metabolizing Enzymes Involved in Cardiovascular Drug Treatment

  2014cites this paper
• Data science approaches to pharmacogenetics.

  2014cites this paper
• The Pathogenesis and Treatments of Diabetes, Questions and Answers

  2014cites this paper
• Applying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogenetics

  2014cites this paper
• Individualized cancer therapy

  2014cites this paper
• Predictive role of repair enzymes in the efficacy of Cisplatin combinations in pancreatic and lung cancer.

  2014cites this paper
• Optimisation de la réponse aux thiopurines par la pharmacogénétique : approches in vitro et cliniques

  2014cites this paper
• Personalized Cancer Therapy: A Perspective

  2014cites this paper
• GENOTYPES FREQUENCIES OF RS9923231 AND RS7294 SNPS IN THE VKORC1 GENE AMONG EMIRATIS AND THEIR IMPLICATIONS FOR WARFARIN DOSAGE

  2014cites this paper
• Différenciation génétique des populations humaines pour les gènes de la réponse aux médicaments

  2014cites this paper
• Molecular Diversity and Association Analysis of Drought and Salt Tolerance in Gossypium hirsutum L. Germplasm

  2014cites this paper
• PHARMACOGENETICS AND PHARMACOGENOMICS IN PERSONALIZED MEDICINE: ROLE OF GENE POLYMORPHISM IN DRUG RESPONSE

  2014cites this paper
• Pharmacogenomics in Developing Countries

  2014cites this paper
• Fast dimension-reduced climate model calibration and the effect of data aggregation

  2013cites this paper
• Genome-wide association mapping for five major pest resistances in wheat

  2013cites this paper
• Insights from genome-wide association studies of drug response.

  2013cites this paper
• Farmakogenetyka w praktyce klinicznej zakażenia HIV

  2013cites this paper
• Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.

  2013cites this paper
• Conducting Clinical Trials in Developing and Emerging Countries: Review and Case Study

  2013cites this paper
• LOODUS- JA TEHNOLOOGIATEADUSKOND MOLEKULAAR- JA RAKUBIOLOOGIA INSTITUUT BIOTEHNOLOOGIA ÕPPETOOL

  2013cites this paper
• Association mapping for soilborne pathogen resistance in synthetic hexaploid wheat

  2013cites this paper
• Antidepressant response and polygenes.

  2013cites this paper
• State-of-the-Art Technologies to Interrogate Genetic/Genomic Components of Drug Response

  2013cites this paper
• Pharmacogenomics in early-phase clinical development.

  2013cites this paper
• Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population.

  2013cites this paper
• Ethical Considerations in Pharmacogenomics

  2013cites this paper
• Pharmacogenomics Study of Clopidogrel by RFLP based Genotyping of CYP2C19 in Cardiovascular Disease Patients in North-East Population of India

  2013cites this paper
• Genetics of Population Differences in Drug Response

  2013cites this paper
• Technological and cost comparison of cytochrome P450 2B6 (516G>T) genotyping methods in routine clinical practice

  2013cites this paper
• New models towards assessing anti-cancer therapeutics.

  2012cites this paper
• Replication Study to Confirm the Role of CYP2D6 Polymorphism rs1080985 on Donepezil Efficacy in Alzheimer's Disease Patients

  2012cites this paper
• Review New models towards assessing anti-cancer therapeutics

  2012cites this paper
• Personalized medicine: is it a pharmacogenetic mirage?

  2012cites this paper
• Pharmacogenetic Basis for Therapeutic Optimization in Alzheimer’s Disease

  2012cites this paper
• In vitro assessment of the allelic variants of cytochrome P450.

  2012cites this paper
• The effect of base-pair sequence on electrochemically driven denaturation.

  2012cites this paper
• Ethnic Sensitive or Molecular Sensitive Beyond All Regions Being Equal in Multiregional Clinical Trials

  2012cites this paper
• A label-free, electrochemical SERS-based assay for detection of DNA hybridization and discrimination of mutations.

  2012cites this paper
• Pharmacogenomics and Nanotechnology Toward Advancing Personalized Medicine

  2012cites this paper
• Pharmacogenetically Driven Treatments for Alcoholism

  2012cites this paper
• Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure

  2012cites this paper
• Limites biológicos, biotecnociência e transumanismo: uma revolução em Saúde Pública?

  2012cites this paper
• Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients

  2012cites this paper
• The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide

  2012cites this paper
• The Development, Validation and Implementation of a Broad-Based ADME Genotyping Assay into Research and Clinical Trials

  2012cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA Programa de Pós-Graduação em Ciências Médicas: Psiquiatria

  2012cites this paper
• PHG Foundation project team and authors

  2011cites this paper
• DRUG TRIAL CONTROVERSIES IN INDIA

  2011cites this paper
• Regulation and Paediatric Drug Trials: Patents, Plans, and Perverse Incentives

  2011cites this paper
• Endodontic Records and Legal Responsibilities

  2011cites this paper
• Pharmacogenetics and Renal Transplantation

  2011cites this paper
• Genetic lotteries within families.

  2011cites this paper
• Identification of novel genomic regions associated with resistance to Pyrenophora tritici-repentis races 1 and 5 in spring wheat landraces using association analysis

  2011cites this paper
• Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses

  2011cites this paper
• Genetics and Genomics

  2011cites this paper